Cat#:Y05801
Name:Recombinant Human EPO
Species:Human
Purity:≥95%
Endotoxin: ≤10 EU/mg
Expression System:CHO
Size: 50μg 1mg
Price: $160.00 $1,220.00
Instruction
Cat#:Y05801
Name:Recombinant Human EPO
Species:Human
Purity:≥95%
Endotoxin: ≤10 EU/mg
Expression System:CHO
Size: 50μg 1mg
Price: $160.00 $1,220.00
General description
Erythropoietin is the primary cytokine regulating red blood cell production from erythroid progenitors. It is essential for maintaining oxygen homeostasis and is widely used to treat anemia. Recombinant Human EPO Protein (Y05801) is expressed from mammalian cells. It contains AA Ala 28 - Arg 193 (Accession # P01588), and is widely used in advanced cell culture, hematology research, and erythroid differentiation studies.
Application
· Erythroid Progenitor Differentiation — Drives the maturation of BFU-E and CFU-E into enucleated red blood cells.
· Hematopoietic Stem Cell Culture — Supports erythroid lineage commitment in cord blood and bone marrow cultures.
· Anemia and Erythropoiesis Research — Models erythroid development and therapeutic erythropoietin responses.
· Cell-Cultured Blood Production — Enables the generation of universal donor red blood cells from stem cells.
· Serum-Free Culture Systems — Suitable for chemically defined and xeno-free cell culture media.
Product Specifications
| Cat. No. | Y05801 |
| Purity | ≥95%, by SDS-PAGE (under reducing & Non-reducing conditions, visualized by Coomassie staining). |
| Endotoxin | ≤10 EU/mg by the LAL method. |
| Bioactivity | Measured in a cell proliferation assay using TF-1 human erythroleukemic cells. The ED50 for this effect is ≤0.1 ng/mL. |
| Accession | P01588 |
| Species | Human |
| Expression System | CHO |
| Mol. Weight | 18.3 kDa |
| Expression Region | Ala28-Arg193 |
| Tag Info | Tag free |
| Formulation | Lyophilized |
| Buffer | Lyophilized from a 0.22 μm-filtered solution containing PBS, 5% Mannitol and 0.01% Tween 80, pH7.4 |
| Lead Time | Products are in stock, but custom products may require further consultation. |
| Shipping | The product is shipped with blue ice. |
Stability and Reconstitution
· 36 months at -20°C to -80°C in lyophilized state;
· 6 months at -20°C to -80°C under sterile conditions after reconstitution;
· 7-10 days at 2°C to 8°C under sterile conditions after reconstitution;
· Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
· It is recommended to redissolve in sterile deionized water.
Backgroud
EPO is a glycoprotein hormone produced primarily by peritubular fibroblasts in the kidney in response to hypoxia. It signals through the EPOR homodimer, activating JAK2-dependent STAT5, PI3K-AKT, and RAS-MAPK pathways to promote erythroid progenitor survival, proliferation, and terminal differentiation. Proper glycosylation is essential for EPO in vivo half-life and bioactivity, making mammalian expression critical for research and therapeutic applications. In cell culture, EPO is indispensable for erythroid differentiation protocols and the emerging field of cultured red blood cell production.
Q&A
Q1: What is EPO mainly used for?
EPO is primarily used for erythroid progenitor differentiation, HSC culture, anemia research, and cell-cultured blood production.
Q2: Is this EPO suitable for serum-free culture systems?
Yes. EastMabBio recombinant EPO is compatible with serum-free, xeno-free, and chemically defined media systems.
Q3: How should recombinant EPO be stored?
Lyophilized protein should be stored at -20°C or below. After reconstitution, aliquot and avoid repeated freeze-thaw cycles.
Q4: What shipping conditions are used?
Products are shipped on dry ice with validated cold-chain packaging to maintain stability during international transportation.
Q5: Do you provide QC documents?
Yes. COA, MSDS, TSE-BSE statements, endotoxin reports, bioactivity data, and additional QC documentation are available upon request.
SDS-PAGE

Recombinant Human EPO (Cat. No. Y05801) was analyzed by SDS-PAGE.
Bioactivity
Recombinant Human EPO (Cat. No.Y05801) stimulates proliferation of TF-1 human erythroleukemic cells. The ED50 for this effect is ≤0.1 ng/mL.


Jiangsu East-Mab Bio:Building 13 and 17, 888 Zhujiang Road, Rudong, Nantong, Jiangsu 226499 , China
Suzhou East-Mab Bio:Floor 5 & 6, Building 1, 168 Majian Road, Suzhou, Jiangsu 215129, China
Platform Information Submission-Privacy Agreement
· Privacy Policy
No content yet
Platform Information Statement-Laws and Regulations
· Laws and regulations
Trademark registration of Jiangsu Dongkang Biomedical Technology Co., Ltd.
East Mab
East Mab Bio
东抗生物
To download COA, please enter the product batch and specification information in the search box.
You can also ask us directly via the following email: dongkang@Sales.com